市場調査レポート

商品コード

1461475

ファーマコビジランスの世界市場規模、シェア、成長分析、タイプ別、用途別、エンドユーザー別-産業予測、2024～2031年

Global PharmaCovigilances Market Size, Share, Growth Analysis, By Type, By Application, By End-User(Pharmaceutical Companies, Contract Research Organizations and Other Healthcare Providers.) - Industry Forecast 2024-2031

出版日: 2024年04月05日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 842,541円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 985,614円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,128,687円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=158.97円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のファーマコビジランス市場規模は、2022年に90億7,000万米ドルと評価され、2023年の97億5,000万米ドルから2031年には173億9,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは7.5％で成長する展望です。

世界のファーマコビジランス市場は、患者の安全性への関心の高まり、規制基準の強化、製薬セグメントの拡大により、大幅な成長を遂げています。この市場分析では、世界のファーマコビジランス市場における主要動向、促進要因・課題、地域差に関する洞察を記載しています。ファーマコビジランス市場の拡大を後押しする極めて重要な要因は、特に薬剤の複雑化と新規治療の出現に直面して、薬剤の安全性をモニタリングする需要が高まっていることです。世界中の規制機関が厳格なガイドラインを施行し、製薬企業に強固なファーマコビジランス・プロトコルの採用を促しているため、市場の成長を後押ししています。さらに、慢性疾患の蔓延と薬剤消費の急増は、ファーマコビジランスの重要性を強調しています。副作用や投薬ミスが患者の健康、医療支出、法的義務に及ぼす影響は、効果的なファーマコビジランス・システムの必要性を強調しています。その結果、医療提供者と規制機関は、有害事象を迅速に特定し対処するための強固なファーマコビジランス・メカニズムの必要性を強調し、それによって患者の安全性と全体的な医療成果を増強しています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主要投資の分析
主要成功要因
競合の程度

市場力学と展望

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

ファーマコビジランスの世界市場：タイプ別

市場概要
社内医薬品安全性監視と契約アウトソーシング医薬品安全性監視

ファーマコビジランスの世界市場：用途別

市場概要
自発的な報告
集中監視プログラム
市販後調査
危機管理
信号の検出と評価
ベネフィット・リスク評価と安全性データベース管理

ファーマコビジランスの世界市場：エンドユーザー別

市場概要
製薬会社
医薬品研究受託機関（CRO）とその他の医療提供者

ファーマコビジランスの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主要市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

QuintilesIMS（米国）
Accenture（アイルランド）
Cognizant（米国）
IBM Corporation（米国）
Oracle Corporation（米国）
PAREXEL International Corporation（米国）
ArisGlobal（米国）
ICON plc（アイルランド）
IQVIA（米国）
PRA Health Sciences（米国）
Wipro Limited（インド）
Capgemini SE（フランス）
Tata Consultancy Services Limited（インド）
BioClinica, Inc.（米国）
Sciformix Corporation（米国）
Covance Inc.（米国）
Bioclinica（米国）
HCL Technologies Ltd.（インド）
Foresight Group International AG（スイス）
TAKE Solutions Ltd.（インド）

Product Code: SQMIG35J2052

Global Pharmacovigilance Market size was valued at USD 9.07 billion in 2022 and is poised to grow from USD 9.75 billion in 2023 to USD 17.39 billion by 2031, growing at a CAGR of 7.5% in the forecast period (2024-2031).

The global pharmacovigilance market has witnessed substantial growth due to heightened attention to patient safety, escalating regulatory standards, and the expanding pharmaceutical sector. This market analysis offers insights into key trends, drivers, challenges, and regional variations within the global pharmacovigilance market. A pivotal factor propelling its expansion is the escalating demand for monitoring drug safety, particularly in the face of burgeoning drug complexity and the advent of novel therapeutics. Regulatory bodies worldwide are enforcing rigorous guidelines, compelling pharmaceutical firms to adopt robust pharmacovigilance protocols, thus propelling market growth. Moreover, the surge in chronic disease prevalence and medication consumption underscores the criticality of pharmacovigilance. The ramifications of adverse drug reactions and medication errors on patient well-being, healthcare expenditure, and legal obligations highlight the imperative for effective pharmacovigilance systems. Consequently, healthcare providers and regulatory entities stress the necessity for robust pharmacovigilance mechanisms to promptly identify and address adverse events, thereby augmenting patient safety and overall healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pharmacovigilance market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmacovigilance Market Segmental Analysis

The global pharmacovigilance market is segmented on the basis of type, application, end-user and region. Based on type, the market can be segmented into In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance. Based on application, the market is segmented into Spontaneous Reporting, Intensive Monitoring Programs, Post-Marketing Surveillance, Risk Management, Signal Detection and Evaluation, Benefit-Risk Assessment and Safety Database Management. By End - user it can be segmented into Pharmaceutical Companies, Contract Research Organizations (CROs) and Other Healthcare Providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Pharmacovigilance Market

The upward trend in adverse drug reactions (ADRs) globally propels the pharmacovigilance market forward, spurred by the expanding use of pharmaceuticals which heightens the likelihood of encountering unforeseen adverse events. Pharmacovigilance assumes a pivotal role in monitoring and documenting ADRs, enabling prompt detection, risk assessment, and implementation of necessary interventions to ensure patient safety. The increasing incidence of ADRs underscores the necessity for pharmacovigilance services and solutions, thus propelling the growth of the market.

Restraints in the Global Pharmacovigilance Market

One of the challenges faced by the global pharmacovigilance market stems from the insufficient awareness and infrastructure in developing regions, which struggle to establish and execute robust pharmacovigilance systems. The lack of understanding regarding the importance of pharmacovigilance, coupled with inadequate regulatory structures and resource limitations, obstructs the uptake of efficient pharmacovigilance protocols. Additionally, the dearth of infrastructure, shortage of trained personnel, and inadequate data management systems present further obstacles to the expansion of the pharmacovigilance market in these areas.

Market Trends of the Global Pharmacovigilance Market

In recent years, there has been a notable surge in drug consumption and development, which, when coupled with prolonged use and widespread usage, poses potential risks of adverse effects for patients. Consequently, the increasing demand for medical oversight from regulatory bodies acts as a catalyst for the expansion of the pharmacovigilance market. Furthermore, the pharmaceutical sector has increasingly embraced pharmacovigilance services, driving growth in this sector. For instance, the collaboration between IQVIA and NRx Pharmaceuticals in September 2021 aimed to offer pharmacovigilance services and medical information, ensuring preparedness for potential regulatory actions. These industry trends underscore the growing acknowledgment of the pivotal role pharmacovigilance plays in ensuring drug safety and regulatory adherence.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global PharmaCovigilances Market by Type

Market Overview
In-House Pharmacovigilance and Contract Outsourcing Pharmacovigilance

Global PharmaCovigilances Market by Application

Market Overview
Spontaneous Reporting
Intensive Monitoring Programs
Post-Marketing Surveillance
Risk Management
Signal Detection and Evaluation
Benefit-Risk Assessment and Safety Database Management.

Global PharmaCovigilances Market by End-User

Market Overview
Pharmaceutical Companies
Contract Research Organizations (CROs) and Other Healthcare Providers.

Global PharmaCovigilances Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

QuintilesIMS (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accenture (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cognizant (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBM Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAREXEL International Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArisGlobal (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IQVIA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PRA Health Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wipro Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Capgemini SE (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tata Consultancy Services Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioClinica, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciformix Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covance Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioclinica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HCL Technologies Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Foresight Group International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TAKE Solutions Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments